6.8 Forslag til videre arbeid
6.8.6 Andre bruksomr˚ader
Attention problems and attention-deficit/hyperactivity disorder in discordant and concordant monozygotic twins: evidence of environmental mediators. J Am Acad Child Adolesc Psychiatry 2007; 46(1):83-91.
22. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Genet 1992; 22(3):337-44.
117
23. Sherman DK, Iacono WG, McGue MK. Attention deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997; 36(6):745-53.
24. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al.
Advancing the neuroscience of ADHD molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:1313–23.
25. Akgün GM, Tufan AE, Yurteri N, Erdoğan A. Dikkat eksikliği hiperaktivite bozukluğunun genetik boyutu. Psikiyatride Güncel YaklaĢımlar 2011; 3(1):15-48.
26. Morrison JR, Stewart MA. The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 1973; 28(6):888-91.
27. Alberts-Corush J, Firestone P, Goodman JT. Attention and impulsivity characteristics of the biological and adoptive parents of hyperactive and normal control children. Am J Orthopsychiatry 1986; 56(3):413-423.
28. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, et al. Segregation analysis of attention deficit hyperactivity disorder. Psychiatr Gen 1992; 2(4):257-75.
29. Biederman J, Faraone SV, Keenan K, Steingard R, Tsuang MT. Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 1991;
148(2):251-56.
30. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child & Adolesc Psychiatry 2000; 39(11):1432-37.
31. Tuğlu C. Dikkat Eksikliği/Hiperaktivite Bozukluğu Olan Çocukların Babalarında Bu Tanının ve Ruhsal Durumun Gözden Geçirilmesi (tez). Edirne: Trakya Üniversitesi Tıp Fakültesi; 1996.
32. Camcıoğlu T. Dikkat Eksikliği Hiperaktivite Bozukluğu Tanısı KonmuĢ Çocukların Ebeveynlerinde Dikkat Eksikliği Hiperaktivite Bozukluğu Sıklığı (tez). Kocaeli: Kocaeli Üniversitesi Tıp Fakültesi; 2009.
33. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder.
Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49(9):728-38.
34. Perrin S, Last CG. Relationship between ADHD and anxiety in boys: Results from a family study. J Am Acad Child Adolesc Psychiatry 1996; 35(8):988-96.
35. Braaten EB, Beiderman J, Monuteaux MC, Mick E, Calhoun E, Cattan G, et al.
Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry 2003; 53(1):93-9.
118
36. Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder features among adults with panic disorder. J Affect Disord 2000;
58(2):99-106.
37. Faraone SV, Biederman J, Keenan K, Tsuang MT. Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients. Psychological Med 1991; 21(1):109-21.
38. Wallis D, Russell HF, Muenke M. Review: Genetics of attention deficit/hyperactivity disorder. J Pediatr Psychol 2008; 33(10):1085-99.
39. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266(13):1793–800.
40. Sevinç E, Erdal ME, Sengul C, Cakaloz B, Ergundu TG, Herken H. Association of adult attention deficit hyperactivity disorder with dopamine transporter gene, Dopamine D3 receptor, and Dopamine D4 receptor gene polymorphisms. Klinik Psikofarmakoloji Bülteni 2010; 20:196-203.
41. Huang YS, Lin SK, Wu YY, Chao CC, Chen CK. A family-based association study of attention-deficit hyperactivity disorder and dopamine D2 receptor TaqI A alleles. Chang Gung Med J 2003; 26(12):897–903.
42. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al.
Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56(4):993-8.
43. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005; 57(11):1215-20.
44. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006; 15(14):2276–84.
45. Zimmer L. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD. Neuropharmacology 2009; 57(7-8): 601–7.
46. Amen DG, Carmichael BD. High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry 1997; 9(2):81-6.
47. Langleben DD, Austin G, Krikorian G, Ridlehuber HW, Goris ML, Strauss HW.
Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. Nucl Med Commun 2001; 22(12):1333-40.
48. Zang YF, He Y, Zhu CZ, Cao QJ, Sui MQ, Liang M, et al. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev 2007;
29(2):83-91.
119
49. Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K, Mazur-Hopkins P, et al.
MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 2002; 116(1-2):63-81.
50. Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2002; 52(8):785–94.
51. Toone B, Clarke M, Young S. Attention-deficit hyperactivity disorder in adults.
Advances in psychiatric treatment 1999; 5:112-9.
52. Ashtari M, Kumra S, Bhaskar SL, Clarke T, Thaden E, Cervellione KL, et al.
Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study.
Biol Psychiatry 2005; 57(5):448–55.
53. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al.
Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288(14):1740-8.
54. Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol
Psychiatry 2005; 57(11):1273–84.
55. Öner Ö, Aysev SA. Dikkat eksikliği hiperaktivite bozukluğu. Aysev S.A, Taner I.Y.
Çocuk ve ergen ruh sağlığı ve hastalıkları. Golden Print; 2007. s.399-415.
56. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, et al.
Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.
Biol Psychiatry 2006; 60(10):1071–80.
57. Duncan J, Owen AM. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci 2000; 23(10):475-83.
58. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4(6):215-22.
59. Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJ. Causal heterogeneity in attention-deficit/hyperactivity disorder: Do we need neuropsychologically impaired subtypes? Biol Psychiatry 2005; 57(11):1224–30.
60. Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD:
The predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol 2010; 25(3):157–73.
61. Öncü B, Ölmez ġ. Dikkat eksikliği ve hiperaktivite bozukluğu olan eriĢkinlerde nöropsikolojik bulgular. Turk Psikiyatri Derg 2004; 15(1):41-6.
120
62. Barkley RA. Behavioral inhibition, sustained attention, and executive functions:
constructing a unifying theory of ADHD. Psychol Bull 1997; 121(1):65-94.
63. Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry 2011; 16(11):1147-54.
64. Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber EW.
Metilfenidate downregulates the dopamine receptor and transporter system in children with ADHD. Neuropediatrics 2003;34(2):77-80.
65. Öncü B, ġenol S. Dikkat eksikliği hiperaktivite bozukluğunun etiyolojisi: Bütüncül yaklaĢım. Klinik Psikiyatri 2002; 5:111-9.
66. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, et al. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 2009; 302(10):
1084-91.
67. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat:
a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
Neuropsychopharmacology 2002; 27(5):699–711.
68. Doğangün B, Yavuz M. Dikkat eksikliği hiperaktivite bozukluğu. Türk Ped ArĢ 2011; 46 Özel Sayı:25-8.
69. Ercan E.S. EriĢkin dikkat eksikliği hiperaktivite bozukluğu. Dönence Basım ve Yayın Hizmetleri; 2010. s.7-104.
70. Martin A. The hard work of growing up with ADHD. Am J Psychiatry 2005;
162(9):1575-7.
71. Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. J Clin Psychol 2005; 61(5):535–47.
72. Hechtman L. ADHD in adults. Brown TE. ADHD comorbidities: Handbook for ADHD complications in children and adults. London: American Psychiatric Publishing, Inc;
2009.p.81-92.
73. ġenol S, ĠĢeri E, Koçkar A. Dikkat eksikliği hiperaktivite bozukluğu. Ankara: Hekimler Yayın Birliği; 2008.s.1-203.
74. Ercan ES. Dikkat eksikliği hiperaktivite bozukluğu. Ġstanbul: Doğan Egmont Yayıncılık ve Yapımcılık Tic A.ġ; 2008. s.11-242.
75. Retz W, Klein RG (eds): Attention-deficit hyperactivity disorder ( ADHD) in adults. Key issues in mental health. Basel, Karger; 2010; 176:1-183.
121
76. Öner Ö, Kılıç EZ. Çocuk ve ergenlerde bipolar affektif bozukluk ve hiperaktivite ayırıcı tanısı. Turk Psikiyatri Derg 2000; 11(1):58-63.
77. Akdemir D, Çetin F. Çocuk ve ergen psikiyatrisi bölümüne baĢvuran ergenlerin klinik özellikleri. Çocuk ve Gençlik Ruh Sağlığı Dergisi 2008; 15(1):5-13.
78. Aktepe E. Dikkat eksikliği hiperaktivite bozukluğu tanısı konan çocuk ve ergenlerde eĢ tanılar ve sosyodemografik özellikler. New/Yeni Symposium 2011; 49:201-08.
79. Sevinç E, ġengül C, Çakaloz B, Herken H. Psikiyatri polikliniğinde eriĢkin dikkat eksikliği hiperaktivite bozukluğu tanısı konan hastalarda eĢ tanı. Arc Neuropsychiatry 2010; 47:139-43.
80. Alyanak FÖ, Yargıç Ġ, Oflaz S. Genel psikiyatri polikliniğinde eriĢkin dikkat eksikliği hiperaktivite bozukluğu sıklığı ve dikkat eksikliği hiperaktivite bozukluğuna eĢlik eden diğer psikiyatrik bozukluklar. Arch Neuropsychiatry 2011; 48:119-24.
81. Ekinci S, Öncü B, Canat S. EriĢkin dikkat eksikliği ve hiperaktivite bozukluğu: EĢ tanı ve iĢlevsellik. Anadolu Psikiyatri Dergisi 2011; 12:185-91.
82. Cumyn L, French L, Hechtman L. Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry 2009; 54(10):673-83.
83. AteĢçi F, Tüysüzoğulları HD, Özdel O, Oğuzhanoğlu NK. EriĢkinlerde bipolar I bozukluk ve dikkat eksikliği hiperaktivite bozukluğu eĢ tanısı: Bir ön çalıĢma. Klinik Psikofarmakoloji Bülteni 2010; 20:66-73.
84. Tufan AE, Yaluğ Ġ. Dikkat eksikliği hiperaktivite bozukluğunda tıbbi eĢ tanılar.
Psikiyatride Güncel YaklaĢımlar 2009; 1(2):187-200.
85. Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant use among children.
Harv Rev Psychiatry 2008; 16(3):151-66.
86. Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry 1999; 156(10):
1515–21.
87. Leung AK, Lemay JF. Attention deficit hyperactivity disorder: an update. Adv Ther 2003; 20(6):305-18.
88. Adler L. Ġssues in the diagnosis and treatment of the adult patient with ADHD. Adv Stud Med 2002; 2(25):902-5.
89. Goodman DW. ADHD in adults: Update for clinicians on diagnosis and assessment.
Primary Psychiatry 2009;16(11):38-47.
90. Öç Yıldız Ö, Ağaoğlu B, Karakaya I, ġiĢmanlar ġG, Çakın Memik N. Dikkat eksikliği hiperaktivite bozukluğu tanılı Türk çocuklarında OROS-metilfenidatın etkinlik ve güvenilirliğinin değerlendirilmesi. Anadolu Psikiyatri Dergisi 2010; 11:44-50.
122
91. Palmini A. Professionally successful adults with attention-deficit/hyperactivity disorder (ADHD). Compensation strategies and subjective effects of pharmacological treatment.
Dementia & Neuropsychologia 2008; 2(1):63-70.
92. Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63(12):10-5.
93. Kessler RC, Lane M, Stang PE,Van Brunt DL. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med 2009; 39(1):137–47.
94. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med.
2005; 47(6):565-72.
95. Halmoy A, Fasmer OB, Gillberg C, Haavik J. Occupational outcome in adult ADHD:
Impact of symptom profile, comorbid psychiatric problems, and treatment a cross- sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 2009;
13(2):175-87.
96. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed 2006; 8(3):12.
97. Barkley RA, Murphy KR. Deficient Emotional self-regulation in adults with attention- deficit/hyperactivity disorder (ADHD): The relative contributions of emotional impulsiveness and ADHD symptoms to adaptive impairments in major life activities. J ADHD Relat Disord 2010; 1(4):5-28.
98. Biederman J, Petty C, Fried R, Fontanella J, Doyle AE, Seidman LJ, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention
deficit hyperactivity disorder. Am J Psychiatry 2006; 163(10):1730–38.
99. Rowe R, Maughan B, Goodman R. Childhood psychiatric disorder and unintentional injury: findings from a national cohort study. J Pediatr Psychol 2004; 29 (2):119-30.
100. Soysal Aġ, Bayoğlu BU, Gücüyener K. Dikkat eksikliği hiperaktivite bozukluğu ile örtülü fiziksel istismar ve ihmal. Çocuk Sağlığı ve Hastalıkları Dergisi 2011; 54:148-53.
101. Özkan T, Sümer N, AyvaĢık B, Er N. KiĢilik özellikleri, koordinasyon becerileri, sürücü davranıĢları ve trafik kazaları. Uluslararası Trafik ve Yol Güvenliği Kongresi ve Fuarı.
8-12 Mayıs, 2002, Gazi Üniversitesi, Ankara.
102. Rosenbloom T, Wultz B. Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers. Accid Anal Prev 2011; 43(1):128-33.
103. Malta LS, Blanchard EB, Freidenberg BM. Psychiatric and behavioral problems in aggressive drivers. Behav Res Ther 2005; 43(11):1467-84.
123
104. Kaya A, Taner Y, Güçlü B, Taner E, Kaya Y, Bahçıvan HG ve ark. Trauma and adult attention deficit hyperactivity disorder. J Int Med Res 2008; 36:9-16.
105. Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 1993; 92(2):212-8.
106. Weafer J, Milich R, Fillmore MT. Driving under the influence of ADHD: research and policy implications. The Guilford Press The ADHD Report 2008; 16(6):1-7.
107. Jerome L, Segal A, Habinski L. What we know about ADHD and driving risk: a literature review, meta-analysis and critique. J Can Acad Child Adolesc Psychiatry 2006;
15(3):105–25.
108. ġengül C, ġengül CB, Öz A, Çaylı H, Kaya K, Herken H. Alkollü araç kullanımı sebebiyle ehliyetine el koyulan sürücülerde eriĢkin tip dikkat eksikliği hiperaktivite bozukluğu sıklığı. Türkiye’de Psikiyatri 2009; 11(3):122-25.
109. Schilling CM, Walsh A, Yun I. ADHD and criminality: A primer on the genetic, neurobiological, evolutionary, and treatment literature for criminologists. J Crim Justice 2011; 39(1):3-11.
110. Retz W,Rösler M. The relation of ADHD and violent aggression: What can we learn from epidemiological and genetic studies? Int J Law Psychiatry 2009; 32(4):235-43.
111. Gudjonsson GH, Sigurdsson JF, Young S, Newton AK, Peersen M. Attention deficit hyperactivity disorder (ADHD). How do ADHD symptoms relate to personality among prisoners? Pers Individ Dif 2009; 47(1):64-8.
112. Gordon V, Williams DJ, Donnelly PD. Exploring the relationship between ADHD symptoms and prison breaches of discipline amongst youths in four Scottish prisons.
Public Health 2012; 126(4):343-8.
113. Çakaloz B, Akay AP, Günay T. KarĢıt olma karĢı gelme bozukluğunun eĢlik ettiği ve etmediği dikkat eksikliği hiperaktivite bozukluğu tanılı çocukların davranıĢsal sorunlar, ders baĢarısı ve akran iliĢkileri açısından değerlendirilmesi. New/Yeni Symposium Journal 2007; 45(2):84-92.
114. Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health 2010;
46(3):209–17.
115. Johnston C, Mash EJ, Miller N, Ninowski JE. Parenting in adults with attention-deficit/hyperactivity disorder (ADHD). Clin Psychol Rev 2012; 32(4):215–28.
116. Robin AL, Payson E. The impact of ADHD on marriage. The ADHD Report 2002;
10:9–13.
117. Tuğlu C, ġahin ÖÖ. EriĢkin dikkat eksikliği hiperaktivite bozukluğu: Nörobiyoloji, tanı sorunları ve klinik özellikler. Psikiyatride Güncel YaklaĢımlar 2010; 2(1):75-116.
124
118. Öncü B, Ölmez ġ, ġentürk V. Wender-Utah Derecelendirme Ölçeği Türkçe formunun eriĢkin dikkat eksikliği ve hiperaktivite bozukluğu’nda geçerlik ve güvenilirlik çalıĢması.
Turk Psikiyatri Derg 2005; 16(4):252-59.
119. Çorapçıoğlu A, Aydemir Ö, Yıldız M, Esen A, Köroğlu E. DSM-IV Eksen I Bozuklukları Ġçin YapılandırılmıĢ Klinik GörüĢme, Klinik Versiyon, SCID-I.
Ankara:Hekimler Yayın Birliği,1999.
120. Sorias S, Saygılı R, Elbi H. DSM-III-R YapılandırılmıĢ Klinik GörüĢmesi Türkçe versiyonu, SCID-II, KiĢilik Bozuklukları Formu. Ġzmir: Ege Üniversitesi Basım Evi;
1990.
121. CoĢkunol H, Bağdiken Ġ, Sorias S. SCID-II (Türkçe versiyonu) görüĢmesinin kiĢilik bozukluklarındaki güvenirliği. Türk Psikoloji Dergisi 1994; 9:26-9.
122. Deffenbacher JL, Lynch RS, Oetting ER, Swaim RC. The driving anger expression inventory: a measure of how people express their anger on the road. Behav Res Ther 2002; 40(6):717-37.
123. EĢiyok B,Yasak Y, Korkusuz Ġ. Trafikte Öfke Ġfadesi: Sürücü Öfke Ġfadesi Envanteri’nin geçerlik ve güvenilirliği. Turk Psikiyatri Derg 2007; 18(3):231-43.
124. Uguz ġ, Ġnanç BY, Yerlikaya EE, Aydın H. Endicott ĠĢte Üretkenlik Ölçeği’nin (EĠÜÖ) Türk toplumunda geçerlilik ve güvenilirliğinin değerlendirilmesi. Turk Psikiyatri Derg 2004; 15(3):209-14.
125. Bulut I. Aile Değerlendirme Ölçeği El Kitabı, ÖzgüzeliĢ Matbaası, Ankara, 1990.
126. Faraone SV, Biederman J, Mick E, Williamson S, Wilens T, Spencer T, et al. Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry 2000;
157(7):1077-83.
127. Hechtman L. Families of children with attention deficit hyperactivity disorder: a review.
Can J Psychiatry 1996; 41(6):350–60.
128. Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, et al. Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 2008; 23(2):142-9.
129. Gibbins C, Weiss MD, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV.
ADHD-hyperactive/impulsive subtype in adults. Mental Illness 2010; 2(1):41-5.
130.Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ.
Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry; 2009; 70(11):1557-62.
125
131. Hermens DF, Williams LM, Lazzaro I, Whitmont S, Melkonian D, Gordon E. Sex differences in adult ADHD: a double dissociation in brain activity and autonomic arousal. Biol Psychol 2004; 66(3):221-33.
132. Hill JC, Schoener EP. Age dependent decline of attention deficit hiyperactivity disorder.
Am J Psychiatry 1996; 153(9):1143-6.
133. Brook U, Boaz M. Attention deficit and hyperactivity disorder (ADHD) and learning disabilities (LD): adolescents perspective. Patient Educ and Couns 2005; 58(2):187-91.
134. Heiligenstein E, Guenther G, Levy A, Savino F, Fulwiler J. Psychological and academic functioning in college students with attention deficit hyperactivity disorder. J Am Coll Health 1999; 47(4):181-5.
135. Riccio CA, Homack S, Jarratt KP, Wolfe ME. Differences in academic and executive function domains among children with ADHD predominantly inattentive and combined types. Arc Clin Neuropsychol 2006; 21(7): 657–67.
136. Matza LS, Paramore C, Prasad M . A review of the economic burden of ADHD. Cost Eff Resour Alloc 2005; 3:5.
137. Shifrin JG, Proctor BE, Prevatt FF. Work performance differences between college students with and without ADHD. J Atten Disord 2010;13(5):489-96.
138. Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative.
Occup Environ Med 2008; 65(12):835-42.
139. Barkley RA. Driving Risks in Adults with ADHD: Yet more evidence and a personal story. The ADHD Report 2006; 14(5):1-9.
140. Nada–Raja S, Langley JD, McGee R,Williams SM, Begg DJ, Reeder AI. Inattentive and hyperactive behaviors and driving offenses in adolescence. J Am Acad Child Adolesc Psychiatry 1997; 36(4):515–22.
141. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007; 38(1):113–28.
142. Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.J Am Board Fam Pract 2004; 17(4):235-9.
143. Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Pediatrics 2006; 118(3):704-10.
126
144. Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, et al.
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008; 96(1-2):145–54.
145. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31(3):328–41.
146. Chronis AM, Lahey BB, Pelham WE, Kipp HL, Baumann BL, Lee SS. Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42(12):1424-32.
147. Faraone SV, Biederman J, Menin D, Wozniak J, Spencer T. Attention deficit hyperactivity disorder with bipolar disorders; a familial subtype? J Am Acad Child Adolesc Psychiatry 1997; 36(10):1378-87.
148. Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. Functional impairment and occupational outcome in adults with ADHD. J Atten Disord 2011.
149. Landine J, McLuckie A. Preparing the ADHD client for the world of work. NATCON Papers. 2005. http://natcon.org/archive/natcon/papers/natcon_papers_2005_e9.pdf.
150. McIntyre RS, Kennedy SH, Soczynska JK, Nguyen HT, Bilkey TS, Woldeyohannes HO, et al. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project.
Prim Care Companion J Clin Psychiatry 2010; 12(3).
151. Matza LS, Johnston JA, Faries DE, Malley KG, Brod M. Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res 2007; 16(9):1511–20.
152. Adler LA, Spencer TJ, Levine LR, Ramsey JL, Tamura R, Kelsey D, et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord 2008; 11(6):720-7.
153. Erickson SR, Guthrie S, VanEtten-Lee M, Himle J, Hoffman J, Santos SF, et al. Severity of anxiety and work-related outcomes of patients with anxiety disorders. Depress Anxiety 2009; 26(12):1165–71.
154. Langlieb AM, Guico-Pabia CJ. Beyond symptomatic improvement: assessing real-world outcomes in patients with major depressive disorder. Prim Care Companion J Clin Psychiatry 2010; 12(2).
155. Reimer B, D’Ambrosio LA, Gilbert J, Coughlin JF, Biederman J, Surman C, et al.
Behavior differences in drivers with attention deficit hyperactivity disorder: the driving behavior questionnaire. Accid Anal Prev 2005; 37(6):996–1004.
156. Barkley RA. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27(2):233–60.
127
157. Shope JT, Waller PF, Raghunathan TE, Patil SM. Adolescent antecedents of high-risk driving behavior into young adulthood: substance use and parental influences. Accid Anal Prev 2001; 33(5):649–58.
158. Deffenbacher JL,White GS, Lynch RS. Evaluation of two new scales assessing driving anger: The Driving Anger Expression Inventory and the Driver’s Angry Thoughts Questionnaire. J Psychopathol Behav Assess 2004; 26(2):87-99.
159. Fischer M, Barkley RA, Smallish L, Fletcher K. Hyperactive children as young adults:
driving abilities, safe driving behavior, and adverse driving outcomes. Accid Anal Prev 2007; 39(1):94–105.
160. Biederman J, Fried R, Hammerness P, Surman C, Mehler B, Petty CR, et al. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD:
160. Biederman J, Fried R, Hammerness P, Surman C, Mehler B, Petty CR, et al. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: